Ligand validation:7ELW

25L: [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate

25L is a Ligand Of Interest in 7ELW designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7ELW_25L_a_801	49%	2%	0.17	0.937	4.52	2.3	23	10	0	0	89%	0.8933
7ELW_25L_b_801	41%	2%	0.183	0.919	4.52	2.34	24	10	0	0	89%	0.8933
4O1P_25L_C_904	86%	8%	0.108	0.978	2.6	2.07	12	14	1	0	100%	1
6M12_25L_a_802	65%	2%	0.139	0.96	4.38	2.36	25	19	0	0	89%	0.8933
6M13_25L_a_802	62%	2%	0.15	0.963	4.35	2.28	23	14	0	0	89%	0.8933
4O1O_25L_B_1000	57%	6%	0.178	0.955	2.73	2.28	10	24	2	0	100%	1
7UCW_25L_A_401	72%	5%	0.11	0.933	3.94	1.47	22	11	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.